CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
CareDx (CDNA) Tops Q3 EPS by 39c, Beats on Revenue; Offers FY24 Revenue Guidance
November 4, 2024 4:27 PM ESTCareDx (NASDAQ: CDNA) reported Q3 EPS of $0.14, $0.39 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $82.9 million versus the consensus estimate of $79.69 million.
GUIDANCE:
CareDx sees FY2024 revenue of $327-331 million, versus the consensus of $326... More
